EUVIMED · CrossrefZeitschrift
Vaccine Insights
ISSN 2752-5422 · BioInsights Publishing, Ltd.
Neueste Artikel
Scaling cell-based vaccine manufacturing: process redesign achieves an approximately 20-fold increase in relative viral titer
Building confidence in innovative vaccine technologies: how flexible, science-based USP standards help translate vaccine innovation into quality, consistency, and public trust
Microarray patches for vaccine delivery: clinical progress and translational challenges
Triplex, a viral vectored CMV vaccine for transplant indications: clinical trial updates
mRNA Vaccines: a growing and complex IP landscape
Will the COVID-19 pandemic lead to a rebirth of research and education on vaccinations in pregnancy?
Developing a protein subunit vaccine for COVID-19
Correlates of protection for SARS-CoV-2 vaccines
A new chapter for the COVID-19 pandemic – and for the vaccines space
Analytical development for rapid response vaccines: start early, think ahead
The human vaccines project: into the immunome
Advancing adjuvants: what’s new & what’s next in vaccine formulation?
Guiding America through a pandemic
RNA vaccines: past, present & future
Vaccine development in the COVID-19 era: regulatory challenges & innovation
Engineering the next generation of vaccine delivery technology
COVID-19: how is the pandemic changing the vaccines space?
Developing broadly protective strategies to protect against future pandemic threats
COVID-19 vaccine supply chain management: a US perspective
Vaccine R&D in the post-COVID-19 era
In search of vaccinology’s Holy Grail: developing a pan-sarbecovirus vaccine
Should we vaccinate against long-COVID?
COVID-19 vaccine supply chain management: a LMIC perspective
Developing a microneedle patch for vaccine delivery
Closing the window of vulnerability: better vaccine adjuvants for neonates
EATRIS: providing the right tools, at the right time, for vaccine development in a pandemic
Embracing complexity
Strengthening regulatory oversight & boosting clinical trial capacity in Africa
Personalized cancer vaccines: more is more?
Opportunities & challenges of applying AI/ML to integrating systems vaccinology studies
EUVIMED